Insider buying last 90 days
No open-market insider purchases were filed for IMAX in the last 90 days.
From Form 4 filings, dated to when each was filed.
Every IMAX insider filing, plotted on the chart in Gekko.Open IMAX in Gekko
Gekko Brief
AI summaryOct 12 closeImax shares have climbed this week on continued momentum from the record box office run of Christopher Nolan's The Odyssey, which delivered a $52 million opening weekend and helped drive Q2 2026 revenue of $103 million, up 12% year-over-year, with adjusted EPS of $0.43. StoneX raised its price target to $65 from $60 while maintaining a Buy rating, citing a strong growth outlook and an adjusted EBITDA margin objective of greater-than-50% expected by 2026. Wedbush added that Imax faces no immediate threat from a reported Disney coalition idea targeting premium screens, pointing to Imax's brand and studio partnerships.
Imax closed at $51.70, up 1.8%, sitting between its 50-day average of $52.35 and 200-day average of $41.75, with the one-year return at 62.2% and the three-month return at 34.3%. The GekkoIndex reads 62.1, placing the stock in the Accumulation zone, up 3.2 over five days. Gekko Fair Value stands at $51.15, putting price 1.1% above that level.
Imax next reports earnings on 22 October 2026, nine days away and within a typical 20-trading-day holding window; its last report saw EPS of $0.14 against a $0.19 estimate, with a 10.4% reaction, against an average absolute reaction of 6.4%. Analyst coverage includes 7 buy and 2 hold ratings among 9 firms, with a consensus target of $56.33, implying 9% upside. Seasonality over the past 5 years shows a 6.1% average 20-day return from this point, rising in 2 of those years.
Written by AI from the Oct 12, 2026 close and checked automatically against the figures on this page.
Imax price vs fair value
Close $51.70200-day averageGekko Fair Value $51.15
Imax quick facts
- Market cap
- $2.84B
- P/E ratio
- 70.3
- Forward P/E
- 29
- EPS, TTM
- $0.73
- Revenue, TTM
- $416.1M
- Profit margin
- 9.8%
- Dividend yield
- —
- Beta
- 0.49
- Volume
- 787,988 avg 1.10M
- 1-year return
- +62.2%
- Typical daily move
- ±4.2%
- Typical 20-day move
- ±6.7%
- 50-day average
- $52.35
- 200-day average
- $41.75
- Next earnings
- Oct 22
- Shares outstanding
- 54.84M
Imax swing-trade checklist
Imax scores 1 supportive, 3 mixed and 1 headwind across the 5 checklist items with data.
Six things swing traders check before a 20-day hold, read from the latest data.
1 supportive3 mixed1 headwind
- Trendmixed
Averages disagree
Close $51.70 sits between the 50-day ($52.35) and 200-day ($41.75) averages, or the averages disagree.
See the chart - GekkoIndexsupportive
62.1, Accumulation
Reading 62.1 is in the Accumulation zone.
See the GekkoIndex - Fair valuemixed
1.1% above
Price is within 5% of Gekko Fair Value (1.1% above).
See fair value - Smart moneyno data
No data
No insider, Congress or unusual options activity in the window.
See smart money - Earnings riskheadwind
Reports in 10 days
Reports on Oct 22, 2026, 10 days away — inside a typical 20-trading-day hold.
See earnings - Seasonalitymixed
+6.1% on average
From this point in the calendar, the next 20 trading days averaged +6.1% over 5 years, rising in 2 of them.
See seasonality
A description of current data, not a recommendation. How this page works
Imax stock chart and price history
Imax closed at $51.70 on Oct 12, 2026, +62.2% over the past year, inside a 52-week range of $30.74 to $57.73.
Close50-day average200-day averageVolume
Use the left and right arrow keys to read daily values.
Performance Breakdown
- 1 month
- −0.7%
- 3 months
- +34.3%
- 6 months
- +40.0%
- 1 year
- +62.2%
The full IMAX chart adds GekkoIndex, insider, options, Congress and hedge fund markers, plus TrendCandles™.Open IMAX in Gekko
Follow Imax through every session
Put IMAX on a Gekko watchlist and see its GekkoIndex, Gekko Fair Value and smart money signals update on the chart as they change.
Track IMAX in GekkoFree for 7 days. No credit card required.
About Imax
Imax builds and supplies technology for large-format cinema, combining proprietary software, custom theater design, specialized equipment and its own intellectual property to create an enhanced movie-watching experience. Its best-known process, DMR, reworks picture and sound from standard films so they can be shown with sharper resolution and fuller audio on Imax screens. The company is widely associated with its branded theater formats, including Imax Dome and Imax 3D, and with the broader "Imax Experience" marketing around them.
Revenue comes through several channels: selling, leasing or sharing revenue on theater systems with exhibitors, supplying digital projection equipment, and offering ongoing and emergency maintenance for installed systems. Imax also distributes and helps produce large-format documentaries, provides post-production and quality-control work, and rents out its large-format film and digital cameras to filmmakers, alongside production support. Customers span commercial multiplexes as well as museums, aquariums, theme parks, educational institutions, home theater buyers and temporary venues such as fairs, reached through direct sales and marketing teams. The company also operates some Imax-branded cinemas itself.
Founded in 1967, Imax is headquartered in Mississauga, Canada. Its shares trade on the NYSE under the ticker IMAX.
- Listed
- NYSE
- Sector
- Consumer durables
- Industry
- Electronics/Appliances
- Website
- imax.com
Imax GekkoIndex: the smart money zone
Imax’s GekkoIndex — Gekko’s 0 to 100 smart money score — reads 62.1, in the Accumulation zone, up 3.2 points over five sessions.
62.1Accumulation
Up 3.2 points over five sessions, from the Neutral zone.
Reading for Oct 12, 2026
What followed past readings in each zone
| Zone | Readings | 5 days | 20 days |
|---|---|---|---|
| Buying | 19 | +3.5% | +19.4% |
| Accumulation (current zone) | 158 | +2.5% | +10.7% |
| Neutral | 421 | +0.5% | +2.0% |
| Distribution | 73 | +0.7% | +2.4% |
| Selling | 11 | +0.9% | +1.5% |
Average IMAX share-price change over the trading days after each daily reading in its GekkoIndex history. Across every stock Gekko tracks, Accumulation readings averaged +2.2% over 20 days. Past behaviour doesn’t guarantee future results.
Accumulation zone: Institutional interest building. About the five zones →
See every daily GekkoIndex reading plotted over the IMAX price, zone by zone.Track IMAX in Gekko
Is Imax stock overvalued? Gekko Fair Value
Imax trades 1.1% above Gekko Fair Value of $51.15, so the shares are about fair value on Gekko’s estimate.
Gekko’s own estimate of what Imax shares are worth, recalculated every trading day.
$51.15
Gekko Fair Value, Oct 10, 2026
1.1% above fair value · About fair value
At the end of Aug 2026 the price was 0.0% above the estimate.
Gekko Fair ValueShare price, month end
Gekko Fair Value on every chart, with the gap to price updating daily.Open IMAX in Gekko
Imax insider and Congress trading
No open-market insider purchases were filed for Imax, and no Congress trades were disclosed, in the last 90 days.
Plus buybacks, unusual options and fund positions, each dated to when it became public.
Congress trades last 90 days
No trades in IMAX were disclosed by members of Congress in the last 90 days.
From congressional disclosures, which report amounts as ranges.
Congress disclosures for IMAX, plotted on the chart in Gekko.Open IMAX in Gekko
Buybacks
Imax has been buying back its own shares.
- Bought back, quarter ended Mar 31, 2026
- $17.45M
- As a share of market cap
- 0.62%
- Trailing four quarters
- $18.93M
From company filings.
Imax earnings: next date and track record
Imax reports on Oct 22, 2026 (10 days away), and beat the EPS estimate in 5 of its last 8 reports.
Next earnings report
Oct 22, 2026
10 days away
- EPS estimate
- $0.76
- Revenue estimate
- $145.8M
5 of 8reports beat the EPS estimate
±6.4%average move across the report
3 of 8reports followed by a gain
Share-price move across each report
Last earnings call, Jul 23, 2026 AI summary
- What they said
- IMAX reported strong Q2 2026 results driven by exceptionally strong box office performance, particularly from Christopher Nolan's The Odyssey. Management highlighted revenue of $103 million (up 12% year-over-year), adjusted EPS of $0.43 (up 65% YoY), and adjusted EBITDA of $48 million with a 46.6% margin. The Odyssey delivered a record global opening for IMAX ($52 million opening weekend like-for-like) and strong weekday and presale performance, generating heightened exhibitor and filmmaker interest, selling out many shows weeks in advance, and driving uplift in system demand and merchandising. Management emphasized disciplined cost control, continued investment in technology and system rollouts, and the potential for continued box office strength in H2 with titles like Dune Part Three and Spider-Man contributing. They reiterated their capital allocation priorities: invest in network growth and opportunistic share repurchases when appropriate. China was called out as a weaker H1 but with signs of recovery and better prospects in H2 and 2027. Management discussed opportunities and constraints around expanding 70mm film systems, merchandising growth, and an IMAX in-vehicle entertainment partnership in China.
- Guidance
- Company reiterated prior guidance for the year and provided a systems/sales range of $160 million to $175 million (aiming toward that range). Management said they are not changing their EBITDA guidance for the year and expect strong box office growth in the back half of 2026 (no explicit numeric EBITDA upgrade provided).
- Risks flagged
- Exposure to volatile film box-office performance and slate timing; China market volatility (disappointing H1 with partial recovery expected); limited scalability and high economics of 70mm film projection systems; dependency on studios and filmmakers to 'lean in' on IMAX format; potential timing and mix variability in JV vs direct system sales; general market and macro risks as noted in forward-looking statement disclaimers.
| Reported | EPS | Revenue | Move |
|---|---|---|---|
| Jul 23, 2026 | $0.14 est $0.19 | $102.8M est $96.09M | +10.4% |
| Apr 30, 2026 | $0.17 est $0.27 | $81.38M est $79.82M | −2.0% |
| Feb 25, 2026 | $0.58 est $0.46 | $125.2M est $120.7M | +13.4% |
| Oct 23, 2025 | $0.47 est $0.35 | $106.2M est $102.9M | −1.1% |
| Jul 24, 2025 | $0.26 est $0.19 | $91.68M est $99.17M | −7.5% |
| Apr 23, 2025 | $0.13 est $0.11 | $86.67M est $92.97M | −0.9% |
| Feb 19, 2025 | $0.27 est $0.29 | $92.67M est $104.1M | −0.3% |
| Oct 30, 2024 | $0.35 est $0.22 | $91.45M est $109.5M | +15.7% |
“Move” is the close of the first session after the report compared with the close of the last session before it, so it reads the same whether the company reported before the open or after the close.
Imax stock forecast and analyst price targets
Analysts’ average 12-month price target for Imax is $56.33, +9.0% from the last close, from 9 firms rating the stock in the last 90 days.
$56.33consensus 12-month target, +9.0% from the last close
Now $51.70Avg $56.33
Low $45High $65
Each firm’s latest rating in the last 90 days: 9 firms.
Latest analyst actions
| Date | Firm | Target | vs price |
|---|---|---|---|
| Oct 9 | Wedbush | $54 | +4.4% |
| Oct 8 | B. Riley Securities | $64 | +23.8% |
| Sep 24 | Morgan Stanley | $63 | +21.9% |
| Sep 21 | B. Riley Securities | $61 | +18.0% |
| Sep 14 | Goldman Sachs | $50 | −3.3% |
+10.7%average 20-day move after past Accumulation readings
+6.1%average move over the next 20 trading days in the last 5 years
±4.2%typical daily move, from the 14-day average range
Gekko doesn’t publish price predictions. These are analyst targets and historical base rates, which don’t guarantee future results.
Imax seasonality: the next 20 trading days
Over the next 20 trading days from Oct 10, Imax averaged +6.1% across the last 5 years, rising in 2 of them.
Next 20 trading days, by year
Average move and hit rate
| Window | Average | Years higher |
|---|---|---|
| Next 5 trading days | +0.5% | 3 of 5 |
| Next 10 trading days | +0.5% | 3 of 5 |
| Next 15 trading days | −0.4% | 2 of 5 |
| Next 20 trading days | +6.1% | 2 of 5 |
| Next 30 trading days | +4.1% | 3 of 5 |
For scale, IMAX’s typical 20-trading-day move in either direction is about 6.7%.
Imax market cap and key statistics
Imax’s market cap is $2.84B, with a P/E ratio of 70.3 and revenue of $416.1M over the last twelve months.
Valuation
- Market cap
- $2.84B
- P/E ratio
- 70.3
- Forward P/E
- 29
- EPS, TTM
- $0.73
- Gekko Fair Value
- $51.15
Trading
- Volume
- 787,988
- Avg volume, 20 days
- 1.10M
- 52-week high
- $57.73
- 52-week low
- $30.74
- Shares outstanding
- 54.84M
Financials
- Revenue, TTM
- $416.1M
- Profit margin
- 9.8%
- Return on equity
- 11%
- Quarterly earnings growth, YoY
- +35.0%
Risk and income
- Beta
- 0.49
- Typical daily move
- ±4.2%
- Typical 20-day move
- ±6.7%
Imax stock news this week
Coverage of Imax this week reads positive: 5 positive, 0 neutral and 0 negative headlines.
- IMAX Corp Share Price - IMAX, RNS News, Articles, Quotes, & Charts (NASDAQ:IMAX)Proactive financial news, Oct 9
- Q&A with IMAX Corp.’s Moji OdebunmiBenefits Canada.com, Oct 9
- IMAX faces no immediate threat from Disney coalition idea, says WedbushProactive financial news, Oct 8
- StoneX raises IMAX stock price target to $65 on strong growth outlookInvesting.com India, Oct 7
- IMAX Shares Rise on Successful Summer BlockbustersFXEmpire, Oct 7
- IMAX: The Odyssey Was A Game Changer, But It Is Just The BeginningSeeking Alpha, Oct 6
Imax peers
Imax’s 6 largest industry peers by market value, with today’s move, GekkoIndex zone and gap to Gekko Fair Value.
| Stock | GekkoIndex zone | vs Fair Value |
|---|---|---|
| SNSharkNinja | Neutral | 14.3% above |
| SONOSonos | Neutral | 12.1% above |
| WHRWhirlpool | Buying | 30.9% below |
| SPBSpectrum Brands | Accumulation | 5.3% above |
| RRRichtech Robotics | Accumulation | 1.3% above |
| TBCHTurtle Beach | Neutral | 5.5% below |
A peer links to its own page where one exists.
Imax stock FAQ
What is Imax’s market cap?
Imax’s market cap is $2.84B at the Oct 12, 2026 close of $51.70, with 54.84M shares outstanding. The shares trade on a P/E ratio of 70.3.
What is the Imax stock forecast?
The consensus analyst 12-month price target for Imax is $56.33, +9.0% from the last close. Of the 9 firms that rated the stock in the last 90 days, 7 rate it a buy, 2 a hold and 0 a sell. Gekko doesn’t publish price predictions of its own.
Is Imax stock overvalued or undervalued?
On Gekko’s estimate Imax is about fair value: the Oct 12, 2026 close of $51.70 is 1.1% above Gekko Fair Value of $51.15. Gekko Fair Value is recalculated every trading day, and a gap inside 5% either way counts as about fair value.
When does Imax report earnings next?
Imax is expected to report on Oct 22, 2026 (10 days away). Analysts expect earnings of $0.76 per share on revenue of $145.8M. Imax beat the earnings estimate in 5 of its last 8 reports, moving 6.4% on average across the report.
What is Imax’s 52-week high and low?
Imax’s 52-week high is $57.73 and its 52-week low is $30.74; it closed at $51.70 on Oct 12, 2026, +62.2% over the past year.
Is Imax stock a buy right now?
Gekko describes the data; it does not make buy or sell recommendations. On the swing-trade checklist, 1 of the 5 items with data read as supportive (gekkoindex), 3 as mixed (trend, fair value and seasonality) and 1 as a headwind (earnings risk). The checklist is a description of current data, not a recommendation.
How this page works
During US trading hours the price at the top of the page is a delayed quote, refreshed every 15 minutes; everything else is rebuilt after each US market close. The GekkoIndex, Gekko Fair Value and the checklist are Gekko’s own, and the Gekko Brief is written by AI from this page’s data and checked against it before it is published. How Gekko’s data works →
See Imax the way Gekko members do
Every GekkoIndex reading, insider trade, options bet and Congress disclosure plotted on the chart, plus the 5,800-name screener and trade planning tools.
Join 1,408 other traders using Gekko
Start Your FREE 7 Day Trial → Every feature unlocked. No credit card required.